Drug Shortage Report for CADUET

Last updated on 2022-11-29 History
Report ID 173298
Drug Identification Number 02273276
Brand name CADUET
Common or Proper name CADUET
Company Name UPJOHN CANADA ULC
Market Status MARKETED
Active Ingredient(s) ATORVASTATIN AMLODIPINE
Strength(s) 80MG 5MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 90
ATC code C10BX
ATC description LIPID MODIFYING AGENTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-09-16
Estimated end date Unknown
Actual end date 2022-11-18
Shortage status Resolved
Updated date 2022-11-29
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-833-287-5646 Email / courriel: UpjohnCanadaCustomerService@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2022-11-29 French Compare
v4 2022-11-29 English Compare
v3 2022-11-02 French Compare
v2 2022-11-02 English Compare
v1 2022-11-02 English Compare

Showing 1 to 5 of 5